MEDDEV 2.12-2 Post-Market Clinical Follow-up Guidance
Get expert support interpreting and applying MEDDEV 2.12-2 Post-Market Clinical Follow-up Guidance for medical devices. Elexes helps manufacturers build defensible PMCF plans, evaluate clinical evidence gaps, align post-market activities with EU MDR expectations, and strengthen documentation for Notified Body review without unnecessary rework or compliance risk.
Our MEDDEV 2.12-2 Services
Targeted PMCF and EU MDR support for planning, reviewing, and strengthening post-market clinical evidence programs.
PMCF Review
Assess existing PMCF plans and evaluation reports against MEDDEV 2.12-2 and EU MDR expectations, identifying evidence gaps, weak rationales, and documentation issues before Notified Body review.
Clinical Evidence Strategy
Develop a proportionate clinical evidence approach that integrates literature, PMCF data, complaint trends, and post-market surveillance outputs to support ongoing clinical evaluation.
PMS Governance
Strengthen complaint handling and post-market surveillance processes so PMCF activities are linked to risk management, vigilance, and periodic regulatory reporting obligations.
EU MDR Alignment
Align PMCF documentation with broader EU MDR technical documentation, including CER updates, Annex III post-market records, and cross-referenced risk management evidence.
Gap Assessment
Benchmark current PMCF documentation and supporting systems against applicable guidance and regulatory expectations, then prioritize remediation actions with clear regulatory rationale.
Regulatory Outsourcing
Extend your internal RAQA capacity with expert support for ongoing PMCF execution, documentation maintenance, authority responses, and post-market compliance governance.
Evidence-Driven Compliance
Build Defensible PMCF Programs
MEDDEV 2.12-2 Post-Market Clinical Follow-up Guidance requires more than a template plan. Elexes helps manufacturers design, review, and strengthen PMCF activities so they are proportionate, scientifically justified, and integrated with CERs, PMS, and risk management. The result is clearer regulatory rationale, stronger post-market evidence, and documentation that stands up to EU MDR and Notified Body scrutiny.
Trusted By Manufacturers
Success Stories
See how manufacturers strengthen PMCF documentation and post-market compliance with expert regulatory support.
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Elexes is a go-to for all FDA regulatory and quality systems work. They outperformed every expectation!”
Kurt Sysock
“Elexes gave us immense support. Their Knowledge and thoroughness were excellent. I look for all of these qualities in consulting firms”
Tom Birney
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for practical, high-rigor regulatory and clinical support.
Deep Expertise
50+ years of collective experience across regulatory, quality, and clinical documentation.
End-to-End Support
Support spans strategy, documentation, remediation, approvals, and ongoing post-market obligations.
Global Coverage
Experienced across FDA, EU MDR, Health Canada, TGA, and other major frameworks.
Proven Results
250+ successful projects and a 90% audit clearance rate support confident execution.
Meet The Elexes Team
Experienced specialists in regulatory, quality, and clinical compliance.
Elexes has built its reputation by helping medical device manufacturers navigate complex regulatory and quality requirements across the full product lifecycle. The company supports organizations from development-stage planning through regulatory approvals, technical documentation, clinical evidence generation, and post-market compliance. With 50+ years of collective experience, the team brings cross-functional expertise spanning EU MDR, FDA, ISO standards, risk management, and clinical documentation. Elexes is trusted by global manufacturers because its consultants combine strategic judgment with hands-on execution, helping clients reduce avoidable rework, strengthen submission quality, and maintain compliant systems after market entry. That practical, end-to-end approach makes Elexes a dependable partner for PMCF and broader regulatory challenges.
200+ Product TypesExperience spanning diverse device categories and technologies.90% Audits ClearedStrong track record supporting inspection and audit readiness.250+ Successful ProjectsDelivered across regulatory, quality, and clinical engagements.
Frequently Asked Questions
What is PMCF in medical devices?
PMCF stands for Post-Market Clinical Follow-Up. It is a continuous process used to collect and evaluate clinical data on a medical device after it is placed on the market. Under EU MDR, PMCF helps confirm safety and performance, identify emerging risks, verify benefit-risk acceptability, and determine whether clinical evaluation conclusions remain valid throughout the device lifecycle.
What is covered under post-market clinical follow-up?
Post-market clinical follow-up covers the planned methods used to gather and assess clinical data after commercialization. This can include PMCF studies, registries, user surveys, literature reviews, complaint trend analysis, and follow-up of adverse events. It also includes documenting the rationale, methods, results, and conclusions in PMCF plans and evaluation reports that support the clinical evaluation and post-market surveillance system.
When is PMCF required under MEDDEV 2.12-2?
MEDDEV 2.12-2 treats PMCF as a generally expected part of post-market clinical evidence generation for many devices, especially where residual risks, long-term performance questions, novel technology, or limited premarket clinical data exist. Under EU MDR, manufacturers must justify the scope of PMCF based on device risk, maturity, claims, and available evidence, rather than assuming it can be omitted without a documented rationale.
What should a PMCF plan include?
A PMCF plan should define the objectives, clinical questions, methods, data sources, timelines, responsibilities, and criteria for evaluating results. It should explain why the selected PMCF activities are appropriate for the device and how outputs will feed into the CER, PMS reports, risk management, and benefit-risk assessment. A strong plan is device-specific, proportionate, and clearly justified.
How does PMCF relate to the Clinical Evaluation Report?
PMCF is one of the key inputs into the Clinical Evaluation Report because it provides ongoing post-market clinical evidence. PMCF findings help confirm whether the device continues to perform as intended, whether residual risks remain acceptable, and whether new hazards or trends have emerged. The CER should reflect PMCF outputs, and inconsistencies between the two documents can raise concerns during review.
Can literature review alone satisfy PMCF requirements?
Literature review may contribute to PMCF, but it is not automatically sufficient on its own. Regulators and Notified Bodies expect the PMCF approach to be justified based on device-specific risk, novelty, claims, and available real-world data. In some cases, literature can support a proportionate PMCF strategy, but many devices require additional methods such as surveys, registries, complaint analysis, or clinical follow-up activities.
What are common PMCF deficiencies found during review?
Common deficiencies include generic PMCF plans, weak justification for chosen methods, missing links to risk management and PMS, unclear clinical objectives, inadequate evaluation of collected data, and reports that do not support CER conclusions. Reviewers also frequently identify poor traceability between PMCF outputs and broader technical documentation, especially where complaint trends, vigilance data, or residual risks are not properly addressed.
How can Elexes help with MEDDEV 2.12-2 compliance?
Elexes helps manufacturers review PMCF adequacy, design proportionate PMCF strategies, strengthen PMCF plans and evaluation reports, and align outputs with CERs, PMS, and risk management files. The team also supports gap assessments, remediation, and broader EU MDR documentation alignment so manufacturers can present a coherent, defensible post-market clinical evidence package during Notified Body review.
Still Need PMCF Clarity?
Speak with our regulatory experts about your PMCF documentation.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality systems expertise.
MDSAP
Supports multi-market audit readiness.
IEC 62304
Software lifecycle compliance expertise.
